OMB Backs Away From Disputed Risk Assessment Policy
In an uncommon victory for the objectivity of the scientific advisory process, the Office of Management and Budget said that it would not implement a proposed new policy on regulatory risk assessments after a National Academy of Sciences panel said the policy was “fundamentally flawed.”
Last January the OMB issued a proposed “bulletin” (pdf) that prescribed new, centralized procedures for performing regulatory risk assessments.
But “the proposed definition of risk assessment in the OMB bulletin departs without justification from long-established concepts and practices,” the NAS panel said.
What’s worse, the proposed changes would mean that “agency risk assessments are more susceptible to being manipulated to achieve a predetermined result.”
Accordingly, the NAS panel recommended that the OMB bulletin be withdrawn. See this January 11 news release on the NAS report.
In light of the NAS critique, the OMB will not finalize the proposed bulletin, Rick Weiss of the Washington Post reported today.
See OMB Watch for further background on the OMB risk assessment proposal and the resulting controversy.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.